Posted by Michael Wonder on 27 Mar 2025
Chlamydia vaccine candidate granted fast track designation by the US FDA
26 March 2025 - The US FDA has granted fast track designation to Sanofi’s mRNA vaccine candidate for the prevention of chlamydia infection.
The decision was based on the potential of the vaccine candidate to address a serious condition and address an unmet public health need.
